Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate

Podobne zapisy

• Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
  od: Sliwa, Jennifer Kern, i wsp.
  Wydane: (2012)
• Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial
  od: Bossie, Cynthia A., i wsp.
  Wydane: (2011)
• Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
  od: Alphs, Larry, i wsp.
  Wydane: (2013)
• Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
  od: Bossie, Cynthia A., i wsp.
  Wydane: (2017)
• Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder
  od: Brown, Brianne, i wsp.
  Wydane: (2017)